Developer docs
API playgroundTry for free, no card

Search company profiles

PreOmics

Full company profile

uuid0002k5m

Namestring
PreOmics
Legal namestring
PreOmics GmbH
Websiteurl
preomics.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

PreOmics GmbH is a proteomics sample-preparation technology company founded in 2016 in Martinsried (near Munich), Germany, by Dr. Nils A. Kulak and Dr. Garwin Pichler, building on research from the Matthias Mann lab. The company develops standardized kits, instruments, and consumables that replace complex, multi-step workflows for preparing proteins and peptides prior to mass spectrometry (MS) analysis. Its core innovation is the iST (indexed Serial Transfer) kit family — all-in-one reagent/consumable kits that reduce sample preparation time from a traditional ~44 hours to approximately 2.5 hours. The product portfolio spans tissue homogenization (BeatBox®), automated sample preparation platforms (PreON®, APP96™), enrichment technologies for plasma/serum/CSF samples (ENRICH-iST, P2-iST), liquid chromatography columns and emitters (PepSep®), add-on modules (SP3, PHOENIX, iST-Fractionation), and a prototype data-visualization tool (ProteoVision™).

PreOmics sells primarily to academic and research institutions, pharmaceutical and biotechnology companies, and clinical research organizations conducting mass spectrometry-based proteomics — with named customers including Philip Morris International, Max Planck Institute of Biochemistry, and University of Oxford. The go-to-market is product-led via direct e-commerce on preomics.com with quote-based pricing (e.g., €1,500 per 12-sample kit, €12,000 per 96-sample kit), complemented by a 15+ country regional distributor network, integrations with five major automation platforms (Agilent, Beckman, Hamilton, Opentrons, Tecan), and distribution through Bruker Corporation's mass-spectrometry channels following Bruker's January 2022 acquisition of a majority stake via a €13.5 million Series B.

In December 2025, PreOmics became part of the Biognosys Group — a Bruker-affiliated consolidation of PreOmics, Biognosys, and biocrates aimed at offering integrated proteomics, metabolomics, and lipidomics solutions. The company holds an exclusive license from EMBL/EMBLEM for SP3 technology in the US and EU, is DIN EN ISO 9001:2015 certified, and has operations in Germany and the US (Billerica, MA).

Short descriptiontext

PreOmics is a German proteomics sample-preparation technology company that develops standardized kits, instruments, and consumables — built on its proprietary iST workflow — to streamline protein and peptide preparation for mass spectrometry analysis, serving academic labs, pharmaceutical/biotech companies, and clinical researchers globally, and now operating as part of the Bruker-affiliated Biognosys Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMartinsried, Germany
HQ citystring
Martinsried
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
proteomics sample preparation, mass spectrometry reagents, protein analysis kits, tissue homogenization instruments, lab automation platforms
Industry3 codes
1Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
CodeHLAGAIAIPrimaryYes
2Proteomics & Mass Spectrometry Services
CodeHLAGANABPrimaryNo
3Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
CodeHLAAAMALPrimaryNo
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Proteomics Sample Preparation Reagents and Instruments
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Kits and Consumables Sales
TypeHardware Sales
Description

PreOmics sells proprietary sample preparation kits and consumables for proteomics research. Products include iST kits (various formats: 4x, 8x, 12x, 96x, 192x), BeatBox tissue kits, ENRICH kits, automation platforms, and chromatography columns. One-time purchase model with repeat customers.

preomics.com
2Instrument Sales
TypeHardware Sales
Description

Sale of laboratory instruments including BeatBox homogenizer, PreON automation system, and APP96 high-throughput platform. Instruments sold alongside consumable kits.

preomics.com
3CRO Services (through Biognosys Group)
TypeProfessional Services
Description

Following 2025 integration into Biognosys Group, PreOmics products support contract research services for proteomics analysis.

preomics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Infrastructure
Pricing details2 tiers
1P2-iST Plasma 12-sample kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,800 / €1,500 per kit

preomics.com
2P2-iST Plasma 96-sample kit (HT)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$14,400 / €12,000 per kit

preomics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1BeatBox®
Description

Tissue homogenization and cell lysis instrument for protein extraction.

preomics.com
+8 more records
Core offering1 text field

PreOmics develops and manufactures standardized sample preparation kits, instruments, and consumables for mass spectrometry-based proteomics. Its core iST (indexed Serial Transfer) kit family delivers all reagents and consumables needed to convert protein and peptide samples into LC-MS-ready analytes, complemented by the BeatBox homogenizer, PreON and APP96 automation platforms, PepSep LC columns, and ENRICH/P2-iST bead-based plasma enrichment kits.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 4-fold improvement in plasma proteome depth and 1.6-fold improvement for CSF compared to non-depleted samples
+4 more records
Product overview1 text field

PreOmics is a proteomics technology company that offers a comprehensive portfolio of products for sample preparation in mass spectrometry-based protein analysis. The core offering centers on the iST kit family - standardized reagents and consumables that streamline the complete workflow from protein/peptide sample preparation to LC-MS analysis. The product ecosystem includes: iST kits (iST, iST-S, iST-BCT, iST-NHS, iST-PSI) for various sample types and processing methods; ENRICH-iST and P2-iST for plasma/serum protein enrichment; BeatBox for tissue homogenization and cell lysis; APP96 and PreON for automation solutions; PepSep columns and emitters for liquid chromatography separation; and add-on modules (SP3, PHOENIX, iST-Fractionation) that extend core functionality. PreOmics became part of Biognosys Group in 2025.

Product and service15 records
1iST Kit
CategorySample preparation kits
2iST-S
CategorySample preparation kits
3iST-BCT
CategorySample preparation kits
4iST-NHS
CategorySample preparation kits
5iST-PSI
CategorySample preparation kits
6ENRICH-iST
CategorySample preparation kits
7P2-iST Plasma
CategorySample preparation kits
8PHOENIX
CategorySample preparation add-ons
9SP3 Add-on
CategorySample preparation add-ons
10iST-Fractionation Add-on
CategorySample preparation add-ons
11BeatBox
CategoryLaboratory instruments
12APP96
CategoryLaboratory instruments
13PreON
CategoryLaboratory instruments
14PepSep Columns and Emitters
CategoryChromatography consumables
15ProteoVision
CategoryData visualization software
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-12-10
Description

As of 2025, PreOmics became part of Biognosys Group alongside biocrates, enabling integrated solutions across proteomics, metabolomics, and lipidomics. The Group brings together PreOmics, Biognosys, and biocrates under Bruker Corporation affiliates.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2020-09-22
Description

Exclusive licensing agreement for EMBL's proprietary SP3 technology, a high-throughput technology for proteomic sample preparation. PreOmics holds exclusive license for SP3 in USA and EU.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-06-04
Description

Co-development and co-marketing agreement focusing on PreOmics iST sample preparation technology integration with Bruker timsTOF Pro platform. Joint development of innovative protein sample preparation and mass spectrometry workflows.

Strategic tierCoreTypeTechnology or Integration
Description

Integration of Biognosys' P2 single particle technology with PreOmics' iST workflow. P2-iST Plasma enables deeper, quantitative proteome coverage in human EDTA plasma samples through bead-based enrichment.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Compatible workflows for PreOmics kits with Agilent automation platforms. Third-party automation solution integration.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Compatible workflows for PreOmics kits with Beckman automation platforms. Third-party automation solution integration.

7Hamilton Robotics
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Compatible workflows for PreOmics kits with Hamilton automation platforms including collaboration on iST-PSI kit development. Third-party automation solution integration.

preomics.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Compatible workflows for PreOmics kits with Opentrons automation platforms. Third-party automation solution integration including P2-iST Plasma on OT2.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Compatible workflows for PreOmics kits with Tecan automation platforms. Collaboration on SP3-iST Add-on kit development. Third-party automation solution integration.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sister company under Biognosys Group (Bruker affiliates); provides CRO/proteomics services and co-developed P2 bead technology used in PreOmics' P2-iST plasma workflow. Most directly comparable as a proteomics-focused sister entity sharing ownership, technology, and customer base.

TypeDirect peer
Description

US-listed proteomics company offering nanoparticle-based sample prep (Proteograph) for deep, unbiased plasma proteomics. Directly competes with PreOmics' ENRICH/P2-iST in the plasma proteomics workflow segment and prompted Bruker's patent challenges on PreOmics' behalf.

TypeDirect peer
Description

Proteomics company specializing in high-multiplex protein biomarker assays (PEA technology). Overlaps with PreOmics in proteomics-based biomarker discovery, especially in plasma/serum, although using affinity-based rather than MS-based workflows.

TypeDirect peer
Description

Proteomics platform (SomaScan) using aptamer-based protein measurement for biomarker discovery at scale. Competes in translational/clinical proteomics applications overlapping with PreOmics' plasma biomarker customers.

TypeDirect peer
Description

Provider of sample preparation technologies (adaptive focused acoustics) used in genomics and proteomics workflows. Comparable as a sample prep tools vendor supplying consumables/instruments to research and clinical labs.

TypeBroad incumbent
Description

Large life sciences reagents/tools vendor offering protein sample preparation and analysis products. Overlaps with PreOmics in proteomics reagents and workflows, but as part of a much broader life sciences portfolio.

TypeBroad incumbent
Description

Dominant mass spectrometry and analytical instrument vendor with bundled sample preparation kits (e.g., EasyPep, in-tip digestion kits). Competes with PreOmics through instrument-tied consumables for its Orbitrap installed base.

TypeBroad incumbent
Description

Major mass spectrometry and LC vendor (ACQUITY, Xevo, Cyclic IMS) with proprietary sample preparation chemistries and workflows for proteomics. Broad incumbent competing for the same MS proteomics customers as PreOmics.

TypeBroad incumbent
Description

Analytical instrument and consumables vendor with automation platforms and proteomics sample prep solutions. Also a PreOmics automation integration partner, illustrating the dual competitor-and-partner dynamic.

TypeBroad incumbent
Description

Antibody and assay reagent vendor serving the proteomics and cell signaling research community. Comparable as a high-quality proteomics reagent supplier, though focused on antibody-based rather than MS-based workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PreOmics

Proteomics Sample Preparation Reagents and Instrumentspreomics.com

PreOmics is a German proteomics sample-preparation technology company that develops standardized kits, instruments, and consumables — built on its proprietary iST workflow — to streamline protein and peptide preparation for mass spectrometry analysis, serving academic labs, pharmaceutical/biotech companies, and clinical researchers globally, and now operating as part of the Bruker-affiliated Biognosys Group.

What PreOmics does

PreOmics GmbH is a proteomics sample-preparation technology company founded in 2016 in Martinsried (near Munich), Germany, by Dr. Nils A. Kulak and Dr. Garwin Pichler, building on research from the Matthias Mann lab. The company develops standardized kits, instruments, and consumables that replace complex, multi-step workflows for preparing proteins and peptides prior to mass spectrometry (MS) analysis. Its core innovation is the iST (indexed Serial Transfer) kit family — all-in-one reagent/consumable kits that reduce sample preparation time from a traditional ~44 hours to approximately 2.5 hours. The product portfolio spans tissue homogenization (BeatBox®), automated sample preparation platforms (PreON®, APP96™), enrichment technologies for plasma/serum/CSF samples (ENRICH-iST, P2-iST), liquid chromatography columns and emitters (PepSep®), add-on modules (SP3, PHOENIX, iST-Fractionation), and a prototype data-visualization tool (ProteoVision™).

PreOmics sells primarily to academic and research institutions, pharmaceutical and biotechnology companies, and clinical research organizations conducting mass spectrometry-based proteomics — with named customers including Philip Morris International, Max Planck Institute of Biochemistry, and University of Oxford. The go-to-market is product-led via direct e-commerce on preomics.com with quote-based pricing (e.g., €1,500 per 12-sample kit, €12,000 per 96-sample kit), complemented by a 15+ country regional distributor network, integrations with five major automation platforms (Agilent, Beckman, Hamilton, Opentrons, Tecan), and distribution through Bruker Corporation's mass-spectrometry channels following Bruker's January 2022 acquisition of a majority stake via a €13.5 million Series B.

In December 2025, PreOmics became part of the Biognosys Group — a Bruker-affiliated consolidation of PreOmics, Biognosys, and biocrates aimed at offering integrated proteomics, metabolomics, and lipidomics solutions. The company holds an exclusive license from EMBL/EMBLEM for SP3 technology in the US and EU, is DIN EN ISO 9001:2015 certified, and has operations in Germany and the US (Billerica, MA).

PreOmics firmographics

Firmographics
Name
PreOmics
Legal name
PreOmics GmbH
Website
https://preomics.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
PreOmics is a German proteomics sample-preparation technology company that develops standardized kits, instruments, and consumables — built on its proprietary iST workflow — to streamline protein and peptide preparation for mass spectrometry analysis, serving academic labs, pharmaceutical/biotech companies, and clinical researchers globally, and now operating as part of the Bruker-affiliated Biognosys Group.
Ownership category
akta.pro rank

PreOmics industry classification

Industry
Product category
Proteomics Sample Preparation Reagents and Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
akta.pro secondary industries
Proteomics & Mass Spectrometry Services (HLAGANAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

  • Proteomics sample preparation
  • Mass spectrometry reagents
  • Protein analysis kits
  • Tissue homogenization instruments
  • Lab automation platforms

Where PreOmics is headquartered

Location

Headquarters

HQ city
Martinsried
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

PreOmics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Kits and Consumables Sales: PreOmics sells proprietary sample preparation kits and consumables for proteomics research. Products include iST kits (various formats: 4x, 8x, 12x, 96x, 192x), BeatBox tissue kits, ENRICH kits, automation platforms, and chromatography columns. One-time purchase model with repeat customers.
  2. Instrument Sales: Sale of laboratory instruments including BeatBox homogenizer, PreON automation system, and APP96 high-throughput platform. Instruments sold alongside consumable kits.
  3. CRO Services (through Biognosys Group): Following 2025 integration into Biognosys Group, PreOmics products support contract research services for proteomics analysis.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goP2-iST Plasma 12-sample kit
Unit PricingPay-as-you-goP2-iST Plasma 96-sample kit (HT)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

PreOmics product offering

Product offering

Core offering

PreOmics develops and manufactures standardized sample preparation kits, instruments, and consumables for mass spectrometry-based proteomics. Its core iST (indexed Serial Transfer) kit family delivers all reagents and consumables needed to convert protein and peptide samples into LC-MS-ready analytes, complemented by the BeatBox homogenizer, PreON and APP96 automation platforms, PepSep LC columns, and ENRICH/P2-iST bead-based plasma enrichment kits.

Product overview

PreOmics is a proteomics technology company that offers a comprehensive portfolio of products for sample preparation in mass spectrometry-based protein analysis. The core offering centers on the iST kit family - standardized reagents and consumables that streamline the complete workflow from protein/peptide sample preparation to LC-MS analysis. The product ecosystem includes: iST kits (iST, iST-S, iST-BCT, iST-NHS, iST-PSI) for various sample types and processing methods; ENRICH-iST and P2-iST for plasma/serum protein enrichment; BeatBox for tissue homogenization and cell lysis; APP96 and PreON for automation solutions; PepSep columns and emitters for liquid chromatography separation; and add-on modules (SP3, PHOENIX, iST-Fractionation) that extend core functionality. PreOmics became part of Biognosys Group in 2025.

Differentiator

Problem solved

Functional benefit

Brands

  • BeatBox®: Tissue homogenization and cell lysis instrument for protein extraction.
  • PepSep®
  • iST
  • iST-BCT
  • ENRICH-iST
  • P2-iST
  • APP96™
  • PreON®
  • ProteoVision™

Products and services

  • iST Kit
  • iST-S
  • iST-BCT
  • iST-NHS
  • iST-PSI
  • ENRICH-iST
  • P2-iST Plasma
  • PHOENIX
  • SP3 Add-on
  • iST-Fractionation Add-on
  • BeatBox
  • APP96
  • PreON
  • PepSep Columns and Emitters
  • ProteoVision

Quantifiable outcome

  • 4-fold improvement in plasma proteome depth and 1.6-fold improvement for CSF compared to non-depleted samples
  • +4 more outcomes

Companies that use PreOmics

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

PreOmics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature7 records

PreOmics partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

  • Biognosys AGflagshipStrategic or Co-development Partner · 10 December 2025As of 2025, PreOmics became part of Biognosys Group alongside biocrates, enabling integrated solutions across proteomics, metabolomics, and lipidomics. The Group brings together PreOmics, Biognosys, and biocrates under Bruker Corporation affiliates.
  • EMBL Enterprise Management Technology Transfer GmbH (EMBLEM)coreOEM/ Whitelabel/ Licensing Partner · 22 September 2020Exclusive licensing agreement for EMBL's proprietary SP3 technology, a high-throughput technology for proteomic sample preparation. PreOmics holds exclusive license for SP3 in USA and EU.
  • Bruker CorporationcoreStrategic or Co-development Partner · 4 June 2019Co-development and co-marketing agreement focusing on PreOmics iST sample preparation technology integration with Bruker timsTOF Pro platform. Joint development of innovative protein sample preparation and mass spectrometry workflows.
  • Biognosys AGcoreTechnology or IntegrationIntegration of Biognosys' P2 single particle technology with PreOmics' iST workflow. P2-iST Plasma enables deeper, quantitative proteome coverage in human EDTA plasma samples through bead-based enrichment.
  • Agilent TechnologiesminorChannel Partner/ Reseller/ DistributorCompatible workflows for PreOmics kits with Agilent automation platforms. Third-party automation solution integration.
  • Beckman CoulterminorChannel Partner/ Reseller/ DistributorCompatible workflows for PreOmics kits with Beckman automation platforms. Third-party automation solution integration.
  • Hamilton RoboticsminorChannel Partner/ Reseller/ DistributorCompatible workflows for PreOmics kits with Hamilton automation platforms including collaboration on iST-PSI kit development. Third-party automation solution integration.
  • OpentronsminorChannel Partner/ Reseller/ DistributorCompatible workflows for PreOmics kits with Opentrons automation platforms. Third-party automation solution integration including P2-iST Plasma on OT2.
  • TecanminorChannel Partner/ Reseller/ DistributorCompatible workflows for PreOmics kits with Tecan automation platforms. Collaboration on SP3-iST Add-on kit development. Third-party automation solution integration.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

PreOmics competitors and assessment

Company assessment

Direct peers

  • Biognosys: Sister company under Biognosys Group (Bruker affiliates); provides CRO/proteomics services and co-developed P2 bead technology used in PreOmics' P2-iST plasma workflow. Most directly comparable as a proteomics-focused sister entity sharing ownership, technology, and customer base.
  • Seer: US-listed proteomics company offering nanoparticle-based sample prep (Proteograph) for deep, unbiased plasma proteomics. Directly competes with PreOmics' ENRICH/P2-iST in the plasma proteomics workflow segment and prompted Bruker's patent challenges on PreOmics' behalf.
  • Olink: Proteomics company specializing in high-multiplex protein biomarker assays (PEA technology). Overlaps with PreOmics in proteomics-based biomarker discovery, especially in plasma/serum, although using affinity-based rather than MS-based workflows.
  • SomaLogic: Proteomics platform (SomaScan) using aptamer-based protein measurement for biomarker discovery at scale. Competes in translational/clinical proteomics applications overlapping with PreOmics' plasma biomarker customers.
  • Covaris: Provider of sample preparation technologies (adaptive focused acoustics) used in genomics and proteomics workflows. Comparable as a sample prep tools vendor supplying consumables/instruments to research and clinical labs.

Broad incumbents

  • Promega: Large life sciences reagents/tools vendor offering protein sample preparation and analysis products. Overlaps with PreOmics in proteomics reagents and workflows, but as part of a much broader life sciences portfolio.
  • Thermo Fisher Scientific: Dominant mass spectrometry and analytical instrument vendor with bundled sample preparation kits (e.g., EasyPep, in-tip digestion kits). Competes with PreOmics through instrument-tied consumables for its Orbitrap installed base.
  • Waters Corporation: Major mass spectrometry and LC vendor (ACQUITY, Xevo, Cyclic IMS) with proprietary sample preparation chemistries and workflows for proteomics. Broad incumbent competing for the same MS proteomics customers as PreOmics.
  • Agilent Technologies: Analytical instrument and consumables vendor with automation platforms and proteomics sample prep solutions. Also a PreOmics automation integration partner, illustrating the dual competitor-and-partner dynamic.
  • Cell Signaling Technology: Antibody and assay reagent vendor serving the proteomics and cell signaling research community. Comparable as a high-quality proteomics reagent supplier, though focused on antibody-based rather than MS-based workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

PreOmics social profiles

Digital presence

PreOmics compliance and trust

Trust signal

Compliance1 record

PreOmics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PreOmics leadership team

Management profile

Number of profiles

Profiles8 records

PreOmics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PreOmics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PreOmics

What does PreOmics do?

PreOmics develops and manufactures standardized sample preparation kits, instruments, and consumables for mass spectrometry-based proteomics. Its core iST (indexed Serial Transfer) kit family delivers all reagents and consumables needed to convert protein and peptide samples into LC-MS-ready analytes, complemented by the BeatBox homogenizer, PreON and APP96 automation platforms, PepSep LC columns, and ENRICH/P2-iST bead-based plasma enrichment kits.

Is PreOmics a public or private company?

PreOmics is a private company. It is classified as corporate owned and is currently operating.

When was PreOmics founded?

PreOmics was founded in 2016. It employs 51 to 100 people.

Where is PreOmics based?

PreOmics is headquartered in Martinsried, Germany, in the Europe region.

How does PreOmics make money?

Three revenue lines are on record. Kits and Consumables Sales are the primary driver. The others are instrument Sales and CRO Services (through Biognosys Group).

Who are PreOmics's main competitors?

Direct peers on record are Biognosys, Seer, Olink, SomaLogic and Covaris. Broad incumbents are Promega, Thermo Fisher Scientific, Waters Corporation, Agilent Technologies and Cell Signaling Technology.

Does PreOmics have an API?

No public API is recorded for PreOmics.

What industry is PreOmics in?

PreOmics's product category is Proteomics Sample Preparation Reagents and Instruments. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comPTAB invalidates key claims of Brigham and Women’s patent By Investing.comThe U.S. Patent Trial and Appeal Board invalidated central claims of U.S. Patent No. 11,435,360 owned by Brigham and Women's Hospital and exclusively licensed to Seer, Inc., striking down the patent's sole independent claim covering nanoparticle-based proteomics detection workflows. PreOmics GmbH and Biognosys AG, both subsidiaries of Bruker Corporation, initiated the inter partes review proceeding IPR2024-01473, successfully arguing the claimed concepts were already known in prior scientific literature. Bruker, with a market capitalization of $5.44 billion, has seen its stock decline 27% year-to-date to $35.69, though the company recently exceeded Q4 revenue expectations at $977.2 million while missing EPS targets.Investing.comPTAB invalidates key claims of Brigham and Women’s patent By Investing.comThe U.S. Patent Trial and Appeal Board invalidated central claims of U.S. Patent No. 11,435,360, owned by Brigham and Women's Hospital and exclusively licensed to Seer, Inc., in inter partes review proceeding IPR2024-01473. PreOmics GmbH and Biognosys AG, subsidiaries of Bruker Corporation, initiated the review and announced that Claim 1 covering nanoparticle-based protein detection workflows was invalidated as lacking novelty or being obvious based on prior scientific literature. The decision weakens Seer's intellectual property position while confirming the position held by Bruker's subsidiaries throughout the proceeding.Stock TitanPreOmics, Biognosys win U.S. patent reviewPreOmics GmbH and Biognosys AG prevailed in U.S. Patent Trial and Appeal Board inter partes review proceeding IPR2024-01473, which revoked the central claims of U.S. Patent No. 11,435,360 owned by The Brigham and Women's Hospital and exclusively licensed to Seer, Inc. The PTAB specifically invalidated Claim 1, which attempted to cover workflows using multiple nanoparticle types to form biomolecule coronas and detect proteins across a wide dynamic range. A Biognosys co-founder stated the outcome confirms the fundamental concepts were already known in scientific literature.BioSpacePreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and ConsumablesMartinsried, Germany-based PreOmics GmbH raised €13.5m in a Series B round led by Bruker Corporation, with Bruker also acquiring a majority stake in a parallel secondary transaction. The company, founded in 2016 by Dr. Garwin Pichler and Dr. Nils A. Kulak, develops automation and consumables for mass spectrometry-based proteomics. Financial terms of the secondary sale were not disclosed.FinSMEsPreOmics Raises €3.3M in Series A FundingPreOmics, a German pre-analytics company for mass spectrometry, raised €3.3M in Series A funding led by Think.Health Ventures with participation from High-Tech Gründerfonds and business angels. The company will use the funds for internationalization and further product development.